What changed?
A sourced timeline of research records and material development changes tracked by BACToBasics for BPC-157. Research-publication dates and clinical-development event dates are labeled separately so they are not mistaken for the same type of update.
Tracked items
4
Research sources
3
Development entries
1
Latest recorded date
Verified 2026-09-05
Latest development activity
Verified 2026-09-05 · Exploratory human evidence · No established development program
BPC-157 has very limited reported human exposure, but there is no established modern clinical-development program demonstrating progression through conventional Phase 1, 2, and 3 milestones.
Open source ↗Latest research record by publication date
Published 2026 · Regulatory · Regulatory evidence review
FDA's 2026 review evaluates the sparse human evidence, extensive preclinical literature, and unresolved safety and quality concerns around BPC-157-related bulk substances.
Open source ↗Tracked timeline
Development changes are dated to the underlying milestone. Research-source entries use the study or source publication year currently stored in the Research Library; that year is not presented as the date BACToBasics added the record.
Exploratory human evidence · No established development program
BPC-157 has very limited reported human exposure, but there is no established modern clinical-development program demonstrating progression through conventional Phase 1, 2, and 3 milestones.
Regulatory · Regulatory evidence review
FDA's 2026 review evaluates the sparse human evidence, extensive preclinical literature, and unresolved safety and quality concerns around BPC-157-related bulk substances.
Human intervention · Uncontrolled pilot study
This very small uncontrolled study is direct human exposure evidence, but it is far below the standard needed to establish efficacy or a general safety profile.
Human intervention · Retrospective chart review
A small retrospective report provides limited direct human evidence but lacks the design needed for reliable efficacy conclusions.
Following a compound creates a clean baseline from the updates currently known. When BACToBasics later records a new research source or material development change, the My Tools update badge can surface it as new for you.
BACToBasics provides educational research organization only. A development milestone does not predict future approval, and a research record does not establish that a compound is safe, effective, approved, or appropriate for use.